Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has received a demand order dated December 26, 2025 from the Office of Deputy/Assistant Commissioner of Central GST & Central Excise, Ahmedabad-North. The order confirms a tax demand of Rs. 24.84 lakh along with an equivalent penalty of Rs. 24.84 lakh, totaling approximately Rs. 49.69 lakh. The alleged issues are non-reversal of excess Input Tax Credit and non-payment of IGST. The company plans to file an appeal before the GST Commissioner (Appeals). Management has stated that there is no material impact expected on the company's financials, operations, or other activities.
The financial impact is relatively minor (~Rs. 49.69 lakh combined demand and penalty) and the company is contesting it through appeal. Shareholders are unlikely to see a significant effect on the stock, though it remains a pending tax dispute worth monitoring for the final outcome.